Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Muscles and nerves that cause goosebumps also help control hair growth.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Created material boosts hair growth and kills bacteria for wound healing.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Advanced human skin models improve drug development and could replace animal testing.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The hair follicle is a great model for research to improve hair growth treatments.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Certain growth factors can promote hair growth in mice by activating hair growth-related proteins.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.